Application of ascorbic acid in the synthesis of rGO/micro-octahedral Cu2O nanocomposites and its effect on the wide linear response range of glucose detection

Free-standing hybrid material of Cu/Cu2O/CuO modified by graphene with commercial Cu foil using for non-enzymatic glucose detection

Free-standing Cu/Cu₂O/CuO modified by graphene was formed through two steps: Firstly, the commercial Cu foil was thermal annealed to form Cu/Cu₂O/CuO; Secondly, the Cu/Cu₂O/CuO was modified by graphene through electrochemical exfoliated method. The SEM, XRD, TEM and XPS have been used to characterize the morphology, the crystalline phase, and the surface composition of the hybrid electrode as-prepared. The effects of Cu and its oxides on graphene has been uncovered by the Raman results. The sensitivity of the glucose sensor in 0.1 M NaOH by using the as-prepared hybrid material reaches 3102μA·mM^-1cm^-2within a linear range of 0.002-2.88 mM, which is better than that of the Cu/graphene and the Cu/Cu₂O/CuO prepared at the same conditions. The sensor also shows excellent anti-interference ability, good cycling stability and time stability. The advantage of the sensor is caused by the strengthened synergistic effects between the graphene and the Cu/Cu₂O/CuO due to the alleviated detrimental effects of the metal on the property of the graphene through using oxides middle layer as well as the large active area that obtained. This work provides a new way to study the effects of graphene in improving the property of the metal oxide especially in using for glucose sensor.

Trending Technology of Glucose Monitoring during COVID-19 Pandemic: Challenges in Personalized Healthcare

The COVID-19 pandemic has continued to spread rapidly, and patients with diabetes are at risk of experiencing rapid progression and poor prognosis for appropriate treatment. Continuous glucose monitoring (CGM), which includes accurately tracking fluctuations in glucose levels without raising the risk of coronavirus exposure, becomes an important strategy for the self-management of diabetes during this pandemic, efficiently contributing to the diabetes care and the fight against COVID-19. Despite being less accurate than direct blood glucose monitoring, wearable noninvasive systems can encourage patient adherence by guaranteeing reliable results through high correlation between blood glucose levels and glucose concentrations in various other biofluids. This review highlights the trending technologies of glucose sensors during the ongoing COVID-19 pandemic (2019-2020) that have been developed to make a significant contribution to effective management of diabetes and prevention of coronavirus spread, from off-body systems to wearable on-body CGM devices, including nanostructure and sensor performance in various biofluids. The advantages and disadvantages of various human biofluids for use in glucose sensors are also discussed. Furthermore, the challenges faced by wearable CGM sensors with respect to personalized healthcare during and after the pandemic are deliberated to emphasize the potential future directions of CGM devices for diabetes management.